Pro-life Organizations Say Biden FDA policy causes 500 daily abortions; Will Trump End it?

Pro-Life Group’s Report on Rising Abortions

A pro-life organization, the Restoration of America Foundation (ROAF), has issued a new report asserting that abortions in the U.S. have been increasing since 2020, primarily due to a Biden-era FDA policy permitting abortion pills to be prescribed through telehealth and delivered by mail. The group claims this policy, which they describe as a COVID-19-related change, is responsible for over 500 mail-order chemical abortions daily, based on data from sources like Guttmacher and WeCount. ROAF argues that the incoming Trump administration has the authority to reverse this policy, potentially curbing the rise in abortions. The report highlights how chemical abortions now dominate, comprising about 63% of all procedures in 2023, up significantly from 39% in 2017.

Statistical Evidence of Abortion Growth

According to the report, abortions have climbed steadily since a low in 2017, with an estimated 916,460 in 2019—the last year mail-order abortions were explicitly illegal. By 2024, the figure is projected to reach around 1.1 million, representing a 22% increase from 2019, far outpacing the 2.9% U.S. population growth over the same period. This surge equates to approximately 170,000 more abortions in 2024 than if rates had stayed at 2019 levels. Additionally, mail-order abortions accounted for about one in four procedures in the first half of 2025, with WeCount data indicating 244,590 do-it-yourself abortions facilitated via telehealth in 2024, including over 120,000 pills shipped into states where abortion is restricted or banned post-Roe v. Wade.

Criticisms of Biden’s FDA Policy and Safety Concerns

The Biden administration’s policy eliminated longstanding safety protocols requiring in-person doctor visits for prescribing mifepristone, allowing telehealth consultations and mail delivery instead. ROAF contends this change relied on insufficient studies and flawed adverse-event data, especially after mandatory reporting for complications was largely removed in 2016 under Obama. A 2021 research paper cited in the report deemed the safety monitoring system “inadequate.” ROAF CEO Doug Truax emphasized the risks, noting about 150 women daily face serious harm like sepsis, hemorrhaging, or death from ectopic pregnancies, framing the issue as both pro-life and a women’s health crisis. He also pointed out how providers in Democrat-led states use shield laws to send pills into restrictive GOP states, undermining local bans.

Urging Trump Administration Action

Despite legal challenges, including a Fifth Circuit ruling that the policy was likely “arbitrary and capricious,” the Supreme Court upheld it due to standing issues. ROAF urges the Trump administration, including HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, to reinstate in-person requirements or remove the drug from the market, citing their promised safety review. Truax warns that failing to act could alienate pro-life supporters, especially as abortions rise to potentially 1.4 million annually by the end of Trump’s term. Republican lawmakers and over 20 attorneys general have echoed these calls, pressing for swift reversal of what they view as Biden’s “dubious” decisions to restore medical safeguards.

Source